Abstract
We thank Drs Nwabudike and Tatu for their interest in our recently published report "Chronic exposure to tetracyclines and subsequent diagnosis for non-melanoma skin cancer in a large Midwestern U.S. patient population" [1]. In their correspondence, Nwabudike and Tatu [2] raised some interesting and thought-provoking questions.
This article is protected by copyright. All rights reserved.
http://ift.tt/2yZQxSj
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου